Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
looks like this will move soon > forget the spread
more news soon?
over hang gone upwards from now!!!
well well well after a major falls last year a major shareholder wants the lot,
well good luck 10p next mth
major miss leading emails sent to a few holders legal action ahead .> if you look at my 2 statements this covers the second one not the first please read before you reply
The shareholder asked if it would not be prudent to halt the share pending discussions with the Government of PNG being resolved .
sent to share holder 4 days before png rns Dear , Thank you for your interest in Nautilus Minerals. The decision to halt the trading of a stock on an exchange is made by the regulatory authorities on the listing exchange. Shares are usually halted to allow enough time for the general market to absorb the impact of any news- positive, negative or indifferent. There is no reason to halt our shares as it is business as usual for for Nautilus: we continue to make positive progress in our discussions with the Government of PNG and are cautiously optimistic that we will have a resolution to the dispute by year end. PNG remains our focus, with the build of our seafloor production system now more than 60% complete. We are continuing to move ahead with our other projects, such as Tonga and the polymetallic nodules in the Clarion Clipperton Zone as well. Should you have any further enquiries please do not hesitate to contact me. Regards, Michael Joyner Investor Relations
maor shareholders want the cmpy to wind up they have no faith in the bod major miss leading emails sent to a few holders legal action ahead
the major players the bod have made sure they are in the usa prier to todays rns they had the chance to suspend the cmpy but are happy to let this freefall now watch out for there usa friends buying this out for nothing it smells bad
the bod have made a real mess and are trying to buy this out on the cheep con con con
First Subjects Enrolled in Phase IIa Clinical Trial of EPODURE Biopumps to Treat Anemia in Patients with End-Stage Renal Disease on Dialysis MISGAV, Israel and SAN FRANCISCO (July 17, 2012) - Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG),the developer of Biopump™, a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announces the launch of its Phase IIa clinical trial in Israel of EPODURE™ Biopumps to treat anemia in patients with end-stage renal disease ("ESRD" or "kidney failure") on dialysis, through the sustained delivery of erythropoietin ("EPO"). Following the Israeli Ministry of Health's recent approval of the trial, Medgenics has enrolled and begun to treat the first two dialysis patients ever to receive EPODURE Biopumps.
The Company is not aware of any reason why the ASX would not allow trading to recommence immediately. i can think of one they have mislead the reh shareholders court action awaits
major deasl on the cards
30% plus one day more to come
£10 this year buy
£7.00 on the cards very soon buy buy buy
dessy spot on baxters tried to buy inn on the very cheep and got told to bog off, the cmpy have a few big investors but will a 10pound to 15pound take over be tempting
what a year much more to come !!!!!!!!
glad to see the long term holders making a few pounds > much more to come